Research

Research at Boston Children's Hospital

The research enterprise at Boston Children’s Hospital, comprising more than 3,000 researchers, is the world’s largest at a pediatric center. Our work is fueled by a deep understanding of disease biology coupled with world-class discovery platforms, including genetics and genomics, gene editing, bioinformatics, proteomics, bioengineering, image analysis, biobanks, disease-specific stem cell lines, and a range of animal models. We have special expertise in rare disease discovery, a robust Translational Research Program and large, diverse patient populations for clinical research and trials.
researchers

More than 3,000 researchers and scientific staff

research space

1 million square feet of research space — and growing

Boston Children's research funding

$423 million in research funding in FY2020 — #1 in NIH funding for pediatric research

Boston Children's Journal articles

3,400 articles/year in peer reviewed journals — the most of any pediatric hospital

Boston Children's inventions

149 new inventions in FY2020 alone

iPSC derived airway infected with SARS-CoV-2. Image: Ruobing Wang, Boston Children’s Hospital

COVID-19 Research

As of March 2021, Boston Children’s Hospital had produced 1,127 COVID-19-related research publications, according to Erudera. These range from molecular investigations of SARS-CoV-2 and the immune response to large-scale clinical studies of the effects of COVID-19 in children.

LEARN MORE

Research Highlights

From our labs and clinics: 10 research advances in 2021

Science can be a long process, so when lab discoveries advance on the road to clinical application, it’s cause to celebrate. A recap of 10 successes poised to change medicine.

LEARN MORE

New research NETs a fresh angle for treating severe inflammation

Serious infections can trigger a runaway inflammatory reaction that can do more harm than the infection itself. New research suggests a novel way to block this response with an existing drug.

LEARN MORE

Finding new targets for acute myeloid leukemia in children

The state of care for acute myeloid leukemia has changed little in decades. But that could change: a search for genes AML needs for basic survival turned up two strong therapeutic leads.

LEARN MORE

An image worth 1,000 words?

The 2021 Science Media Exhibition solicited more than 40 science image submissions from research laboratories and programs throughout Boston Children’s Hospital. The images here were presented live during a virtual event held in June in conjunction with Dr. M. Judah Folkman Research Day.

Follow us on Twitter

BCH Innovation News @BCH_Innovation 1/28/2022 7:30:00 PM
A cool new technology could set the stage for tapping #enteroendocrine cells to reverse diabetes, obesity, and GI c… https://t.co/rmhrDAguhT
BCH Innovation News @BCH_Innovation 1/27/2022 6:00:05 PM
#HiringNow: Do you have a passion for storytelling and writing #science communications? Apply now to join our team… https://t.co/z6ZutEcfwM
BCH Innovation News @BCH_Innovation 1/27/2022 3:00:01 PM
Amid pressing #mentalhealth needs in children, primary care practices struggle to get help – @atchien, @ermeara & c… https://t.co/MSclkFy7oK
BCH Innovation News @BCH_Innovation 1/27/2022 2:24:06 PM
RT @MiachOrtho: The BEAR Implant is available in New York City! Congratulations to @BillLevineMD and the team at @ColumbiaMed for completin…
BCH Innovation News @BCH_Innovation 1/26/2022 9:05:28 PM
#Cerebralpalsy is usually attributed to birth-related factors. But in this first-of-its-kind study, Drs. Sid Srivas… https://t.co/MMXxdcikBT
BCH Innovation News @BCH_Innovation 1/25/2022 9:00:01 PM
Why don’t people with #COVID19 symptoms get tested – even when it’s free? A study in the UK, in @PLOSGPH authored b… https://t.co/yyYbU09ZhM
The commitment and compassion with which we care for all children and families is matched only by the pioneering spirit of discovery and innovation that drives us to think differently, to find answers, and to build a better tomorrow for children everywhere.

Kevin B. Churchwell, President and CEO